Universitätsklinikum Ulm; Klinik für Urologie
About Universitätsklinikum Ulm; Klinik für Urologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
5
Technical University of Munich
1
Clinical Trials at Universitätsklinikum Ulm; Klinik für Urologie
During the past decade, Universitätsklinikum Ulm; Klinik für Urologie conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Atezolizumab Compared With Chemotherapy in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer [IMvigor211]
2015-01-13
2018-11-08
Completed
931
A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection
2015-10-05
2022-06-14
Completed
809
A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract
2016-11-30
2022-12-12
Completed
1,005
Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder
2019-02-04
2023-08-01
Active, not recruiting
33
A Study of Atezolizumab in Combination With Cabozantinib Compared to Cabozantinib Alone in Participants With Advanced Renal Cell Carcinoma After Immune Checkpoint Inhibitor Treatment
2020-07-28
2024-03-01
Active, not recruiting
522
A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy
2021-05-03
2027-11-22
Recruiting
520
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Ulm; Klinik für Urologie"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Chugai" with 1 trials as a collaborator and "Exelixis" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at Universitätsklinikum Ulm; Klinik für Urologie
According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Ulm; Klinik für Urologie" are
"Bladder Cancer" (1 trials), "Carcinoma, Renal Cell" (1 trials), "Carcinoma, Transitional Cell" (1 trials), "Muscle-invasive Bladder Cancer" (1 trials) and "Urinary Bladder Cancer" (1 trials). Many other conditions were trialed in "Universitätsklinikum Ulm; Klinik für Urologie" in a lesser frequency.
Clinical Trials Intervention Types at Universitätsklinikum Ulm; Klinik für Urologie
Most popular intervention types in "Universitätsklinikum Ulm; Klinik für Urologie" are "Drug" (6 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (4 trials), "Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody" (1 trials), "Cabozantinib" (1 trials), "Docetaxel" (1 trials) and "Nivolumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Universitätsklinikum Ulm; Klinik für Urologie
The vast majority of trials in "Universitätsklinikum Ulm; Klinik für Urologie" are
6 trials for "All" genders.
Clinical Trials Status at Universitätsklinikum Ulm; Klinik für Urologie
Currently, there are NaN active trials in "Universitätsklinikum Ulm; Klinik für Urologie".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Universitätsklinikum Ulm; Klinik für Urologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Universitätsklinikum Ulm; Klinik für Urologie, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".